| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-144 |
Sentence |
denotes |
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. |
| T1 |
0-144 |
Sentence |
denotes |
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. |
| TextSentencer_T2 |
145-156 |
Sentence |
denotes |
UNLABELLED: |
| T2 |
145-156 |
Sentence |
denotes |
UNLABELLED: |
| TextSentencer_T3 |
157-303 |
Sentence |
denotes |
Epithelial ovarian cancer (EOC) is a disease responsible for more deaths among women in the Western world than all other gynecologic malignancies. |
| T3 |
157-303 |
Sentence |
denotes |
Epithelial ovarian cancer (EOC) is a disease responsible for more deaths among women in the Western world than all other gynecologic malignancies. |
| TextSentencer_T4 |
304-414 |
Sentence |
denotes |
There is urgent need for new therapeutic targets and a better understanding of EOC initiation and progression. |
| T4 |
304-414 |
Sentence |
denotes |
There is urgent need for new therapeutic targets and a better understanding of EOC initiation and progression. |
| TextSentencer_T5 |
415-716 |
Sentence |
denotes |
We have previously identified the polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3) gene, a member of the GalNAc-transferases (GalNAc-Ts) gene family, as hypomethylated and overexpressed in high-grade serous EOC tumors, compared to low malignant potential EOC tumors and normal ovarian tissues. |
| T5 |
415-716 |
Sentence |
denotes |
We have previously identified the polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3) gene, a member of the GalNAc-transferases (GalNAc-Ts) gene family, as hypomethylated and overexpressed in high-grade serous EOC tumors, compared to low malignant potential EOC tumors and normal ovarian tissues. |
| TextSentencer_T6 |
717-837 |
Sentence |
denotes |
This data also suggested for a role of GALNT3 in aberrant EOC glycosylation, possibly implicated in disease progression. |
| T6 |
717-837 |
Sentence |
denotes |
This data also suggested for a role of GALNT3 in aberrant EOC glycosylation, possibly implicated in disease progression. |
| TextSentencer_T7 |
838-1100 |
Sentence |
denotes |
To evaluate differential glycosylation in EOC caused by modulations in GALNT3 expression, we used a metabolic labeling strategy for enrichment and mass spectrometry-based characterization of glycoproteins following GALNT3 gene knockdown (KD) in A2780s EOC cells. |
| T7 |
838-1100 |
Sentence |
denotes |
To evaluate differential glycosylation in EOC caused by modulations in GALNT3 expression, we used a metabolic labeling strategy for enrichment and mass spectrometry-based characterization of glycoproteins following GALNT3 gene knockdown (KD) in A2780s EOC cells. |
| TextSentencer_T8 |
1101-1186 |
Sentence |
denotes |
A total of 589 differentially expressed glycoproteins were identified upon GALNT3 KD. |
| T8 |
1101-1186 |
Sentence |
denotes |
A total of 589 differentially expressed glycoproteins were identified upon GALNT3 KD. |
| TextSentencer_T9 |
1187-1368 |
Sentence |
denotes |
Most identified proteins were involved in mechanisms of cellular metabolic functions, post-translational modifications, and some have been reported to be implicated in EOC etiology. |
| T9 |
1187-1368 |
Sentence |
denotes |
Most identified proteins were involved in mechanisms of cellular metabolic functions, post-translational modifications, and some have been reported to be implicated in EOC etiology. |
| TextSentencer_T10 |
1369-1579 |
Sentence |
denotes |
The GALNT3-dependent glycoproteins identified by this metabolic labeling approach support the oncogenic role of GALNT3 in EOC dissemination and may be pursued as novel EOC biomarkers and/or therapeutic targets. |
| T10 |
1369-1579 |
Sentence |
denotes |
The GALNT3-dependent glycoproteins identified by this metabolic labeling approach support the oncogenic role of GALNT3 in EOC dissemination and may be pursued as novel EOC biomarkers and/or therapeutic targets. |
| TextSentencer_T11 |
1580-1604 |
Sentence |
denotes |
BIOLOGICAL SIGNIFICANCE: |
| T11 |
1580-1604 |
Sentence |
denotes |
BIOLOGICAL SIGNIFICANCE: |
| TextSentencer_T12 |
1605-1756 |
Sentence |
denotes |
Knowledge of the O-glycoproteome has been relatively elusive, and the functions of the individual polypeptide GalNAc-Ts have been poorly characterized. |
| T12 |
1605-1756 |
Sentence |
denotes |
Knowledge of the O-glycoproteome has been relatively elusive, and the functions of the individual polypeptide GalNAc-Ts have been poorly characterized. |
| TextSentencer_T13 |
1757-1896 |
Sentence |
denotes |
Alterations in GalNAc-Ts expression were shown to provide huge variability in the O-glycoproteome in various pathologies, including cancer. |
| T13 |
1757-1896 |
Sentence |
denotes |
Alterations in GalNAc-Ts expression were shown to provide huge variability in the O-glycoproteome in various pathologies, including cancer. |
| TextSentencer_T14 |
1897-2149 |
Sentence |
denotes |
The application of a chemical biology approach for the metabolic labeling and subsequent characterization of O-glycoproteins in EOC using the Ac4GalNAz metabolite has provided a strategy allowing for proteomic discovery of GalNAc-Ts specific functions. |
| T14 |
1897-2149 |
Sentence |
denotes |
The application of a chemical biology approach for the metabolic labeling and subsequent characterization of O-glycoproteins in EOC using the Ac4GalNAz metabolite has provided a strategy allowing for proteomic discovery of GalNAc-Ts specific functions. |
| TextSentencer_T15 |
2150-2307 |
Sentence |
denotes |
Our study supports an essential role of one of the GalNAc-Ts - GALNT3, in EOC dissemination, including its implication in modulating PTMs and EOC metabolism. |
| T15 |
2150-2307 |
Sentence |
denotes |
Our study supports an essential role of one of the GalNAc-Ts - GALNT3, in EOC dissemination, including its implication in modulating PTMs and EOC metabolism. |
| TextSentencer_T16 |
2308-2456 |
Sentence |
denotes |
Our approach validates the use of the applied metabolic strategy to identify important functions of GalNAc-Ts in normal and pathological conditions. |
| T16 |
2308-2456 |
Sentence |
denotes |
Our approach validates the use of the applied metabolic strategy to identify important functions of GalNAc-Ts in normal and pathological conditions. |